Clinical trials
Completed Phase 2/3 Myelodysplastic Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chimeric Therapies | 1 |
| Eli Lilly and Company | 1 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 1 |
| Gamida Cell -Teva Joint Venture Ltd. | 1 |
| Kyntra Bio | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| National Cancer Institute (NCI) | 1 |
| Roswell Park Cancer Institute | 1 |
| Royal Marsden NHS Foundation Trust | 1 |
| The University of New South Wales | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 11 |
| Leukemia, Myeloid, Acute | 7 |
| Leukemia | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Anemia, Refractory, with Excess of Blasts | 4 |
| Leukemia, Myeloid, Accelerated Phase | 3 |
| Leukemia, Myeloid, Chronic-Phase | 3 |
| Lymphoma | 3 |
| Anemia, Refractory | 2 |
| Congenital Abnormalities | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.